Does Introduction Of A Utility Model Protection Regime Make Sense In India? 13/07/2011 by Intellectual Property Watch 2 Comments India has at least seven diverse intellectual property (IP) legislations related to protection already in place. Its focus should therefore arguably be directed – along the lines of many other IP jurisdictions – on more stringent enforcement modus operandi of the IP rights. Is there scope for introducing yet another IP legislation – the utility model protection law – in the Indian IP landscape and if so, what should be its scope and implication, asks Swarup Kumar.
Amending Canada’s Access To Medicines Regime (CAMR): The New Fate Of Bill C-393 28/06/2011 by Intellectual Property Watch 4 Comments A Canadian bill to improve global access to medicines might get another shot in the new Parliament, writes Daniele Dionisio.
Brazil’s Copyright Reform: Are We All Josef K.? 12/05/2011 by Intellectual Property Watch 8 Comments Discussions are heating up as never before on Brazil’s copyright reform, and controversies involving the new administration as well as the collecting society (ECAD)’s alleged wrongdoings are jeopardising the last eight years of Lula’s administration, according to an updated timeline and analysis by Pedro Paranaguá.
Trading’s End: Is ACTA The Leading Edge Of A Protectionist Wave? 06/05/2011 by Intellectual Property Watch 4 Comments Government policymakers are stalling on trade liberalization while erecting new nontransparent trade barriers, writes Frederick Abbott.
Plant Breeder’s Rights – A Blessing Or A Curse? 20/04/2011 by Intellectual Property Watch 1 Comment Niels Louwaars of the Centre for Genetic Resources, Wageningen University, The Netherlands, discusses the importance of plant breeder’s rights. He makes the case for a carefully balanced protection for plant breeders and changes to patents in agriculture, in order to ensure a competitive, diversified supply of plant varieties and seeds.
Financial Transaction Tax: A Resource For WHO Global Strategy And Plan of Action 07/04/2011 by Intellectual Property Watch 1 Comment A recent European Parliament resolution on a European Financial Transaction Tax could represent an important resource for a WHO-led initiative to find sustainable financing for research into diseases afflicting poor populations.
Caribbean IP: Establishing An Arbitral Tribunal For The Region 11/03/2011 by Intellectual Property Watch 4 Comments The use of arbitration across the Caribbean has been largely within the context of trade union disputes and is still something of a novelty in resolving commercial and private disputes in the region, Abiola Inniss writes.
In Brazil And The IP World, It’s Tropicalization Time! 04/03/2011 by Intellectual Property Watch 2 Comments Benny Spiewak writes: There used to be a time when Brazil meant almost exclusively Carnival, Samba and Soccer. Well, those days are over and there is an undeniable message that will echo through the knowledge-based, creative, innovative world: Wake-Up, World, It’s Tropicalization Time!
Building A Consensus To Address The Health Threat Posed By Fake Medicines 25/02/2011 by Intellectual Property Watch 1 Comment On the eve of a meeting of the WHO working group on substandard/spurious/falsely-labelled/falsified/counterfeit medical products, research-based pharmaceutical industry group IFPMA sets out thoughts on building global consensus to address fake medicines.
Brazil And The Defence Of Public Health: Do As I Say, Not As I Do 17/02/2011 by Intellectual Property Watch 3 Comments A recent decision issued by Advocacia-Geral da União (Advocacy-General of the Union) restricts the role performed by Anvisa – the National Agency for Health Surveillance – in examining pharmaceutical patent applications. This may represent a huge setback for commitments made by Brazilian government related to the protection of public health, writes Felipe Carvalho.